These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2537593

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Apr 01; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 25. [Spontaneous regression of a large liver tumor with markedly elevated serum enzyme levels].
    Siegel EG, Hartmann H.
    Z Gastroenterol; 1987 Dec 01; 25(12):764-8. PubMed ID: 2830733
    [Abstract] [Full Text] [Related]

  • 26. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.
    Tesluk H, Lawrie J.
    Arch Pathol Lab Med; 1981 Jun 01; 105(6):296-9. PubMed ID: 6263214
    [Abstract] [Full Text] [Related]

  • 27. [Liver cell carcinoma associated with oral contraceptives (author's transl)].
    Leclère J, Meot B, Marchal F, Mizrahi R, Collard F, Rauber G, Hartemann P.
    Ann Endocrinol (Paris); 1977 Jun 01; 38(6):361-2. PubMed ID: 206178
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Are oral contraceptive-associated liver cell adenomas premalignant?
    Tao LC.
    Acta Cytol; 1992 Jun 01; 36(3):338-44. PubMed ID: 1316028
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Hepatic adenomas and oral contraceptives. Report of two cases and review of the literature (author's transl)].
    Sabriá Leal M, Mateu Ratera M, Canals Cadafalch J, Blanch Mortes MD, Munuera Gifre E.
    Med Clin (Barc); 1979 Oct 10; 73(6):234-8. PubMed ID: 547127
    [Abstract] [Full Text] [Related]

  • 37. A 42-year-old woman with liver masses and long-term use of oral contraceptives.
    Ye MQ, Suriawinata A, Ben Haim M, Parsons R, Schwartz ME.
    Semin Liver Dis; 1999 Oct 10; 19(3):339-44. PubMed ID: 10518313
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.